Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001213900-24-094762
Filing Date
2024-11-06
Accepted
2024-11-06 07:30:29
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-11-06

Document Format Files

Seq Description Document Type Size
1 FORM ARS ea0219744-03.pdf ARS 633779
  Complete submission text file 0001213900-24-094762.txt   871124
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36374 | Film No.: 241429244
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)